FilingFirehose · free AI preview
4D Molecular Therapeutics, Inc.
FDMT · AI-generated SEC analysis preview · refreshes when data changes
4D Molecular Therapeutics (FDMT) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, indicating operational stability in the near term. However, low signal in a 90-day window does not reflect underlying risk; a biotech firm's real vulnerabilities often emerge in dilution patterns, financing history, and longer-term governance trends. The full $49 Report expands to a 12-month view, adds dilution risk scoring, maps historical 8-K context, and flags AI-detected stress signals in SEC filings. This deeper analysis reveals exposures that routine monitoring misses.
Want the full 5-section $49 Report on FDMT?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.